Antitumor Effect of a Splenic Injection of 5-Fluorouracil on Metastatic Liver Cancer in Mice

The regional administration of 5-fluorouracil (5-FU) has been the fundamental therapy against liver metastases for the improvement of patient prognosis; however, there have been few reports about the immunological effects of this agent. It is also unknown whether it affects the spleen, one of the major lymphoid organs. The objective of the present study was to determine the immunological effect of an intrasplenic injection of 5-FU against liver metastases. We investigated the effect of an intrasplenic injection of 5-FU on the formation of experimental liver metastasis resulting from an intraportal vein injection of colon 26 carcinoma cells in BALB/c mice and elucidated some of the underlying mechanisms involving the effects of this on cellular immunity. Liver metastases were significantly diminished by the splenic injection of 5-FU, particularly in comparison with the portal injection or systemic administration. This was followed by augmentation of the interleukin-12 (IL-12) level in the spleen and activation of hepatic mononuclear cells. In those cells, NK1.1+ (NKT) cells played a central role against metastases. A splenic injection of 5-FU is more effective on the involution of liver metastases than portal or systemic injection. This effect may be attributed to the augmentation of the IL-12 level in the spleen and of NKT cells in the liver rather than to the original effect of 5-FU, which is the so-called inhibition of DNA synthesis.

[1]  W. Wolberg,et al.  Effect of fluoropyrimidines on delayed cutaneous hypersensitivity. , 1965, Cancer research.

[2]  R. Deconti,et al.  Immunosuppression by 5‐fluorouracil , 1970, Cancer.

[3]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[4]  M. Berenbaum.  The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracil. , 1979, Chemotherapy.

[5]  M. Sugiyama,et al.  Enhancement of delayed hypersensitivity reaction with varieties of anti- cancer drugs. A common biological phenomenon , 1981, The Journal of experimental medicine.

[6]  R. Wiltrout,et al.  Role of NK cells in the control of metastatic spread and growth of tumor cells in mice , 1982, International journal of cancer.

[7]  Craig W. Reynolds,et al.  Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver , 1984, The Journal of experimental medicine.

[8]  S. Tashiro,et al.  Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX2 cancer injected into rabbit liver. , 1986, Cancer research.

[9]  G. Trinchieri,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[10]  R. Mosley,et al.  Immune recognition by cytotoxic T lymphocytes of minor histocompatibility antigens expressed on a murine colon carcinoma line. , 1989, Cellular immunology.

[11]  N. Ackerman.  Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases. , 1991, American journal of surgery.

[12]  Y. Shiratori,et al.  Inhibition of hepatic metastasis of colon carcinoma by asialo GM1–positive cells in the liver , 1992, Hepatology.

[13]  G. Trinchieri,et al.  Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. , 1992, Journal of immunology.

[14]  L. Luistro,et al.  Antitumor and antimetastatic activity of interleukin 12 against murine tumors , 1993, The Journal of experimental medicine.

[15]  G. Trinchieri,et al.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. , 1994, Blood.

[16]  H. Fujiwara,et al.  Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells. , 1995, International immunology.

[17]  K. Takeda,et al.  Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. , 1995, Journal of immunology.

[18]  H. Takahashi-Iwanaga,et al.  Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells. , 1995, Journal of immunology.

[19]  T. Starzl,et al.  Changes of liver-resident NK cells during liver regeneration in rats. , 1995, Journal of immunology.

[20]  M. Colombo,et al.  Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. , 1996, Journal of immunology.

[21]  H. Watanabe,et al.  Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice , 1997, Immunology.

[22]  H. Yoshida,et al.  cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro , 1998, Cancer Immunology, Immunotherapy.

[23]  K. Takeda,et al.  Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice. , 1999, Cellular immunology.

[24]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[25]  H. Macdonald,et al.  Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells , 2000, European journal of immunology.

[26]  K. Takeda,et al.  Interleukin-12 Administration Is More Effective for Preventing Metastasis than for Inhibiting Primary Established Tumors in a Murine Model of Spontaneous Hepatic Metastasis , 2002, Surgery Today.

[27]  E. Wisse,et al.  Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma , 2004, Cancer Immunology, Immunotherapy.

[28]  Y. Shiratori,et al.  Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver , 1995, Digestive Diseases and Sciences.